CN105148206A - Traditional Chinese medicine for treating coronary heart disease - Google Patents
Traditional Chinese medicine for treating coronary heart disease Download PDFInfo
- Publication number
- CN105148206A CN105148206A CN201510687048.9A CN201510687048A CN105148206A CN 105148206 A CN105148206 A CN 105148206A CN 201510687048 A CN201510687048 A CN 201510687048A CN 105148206 A CN105148206 A CN 105148206A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- heart disease
- coronary heart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicine for treating coronary heart disease. The traditional Chinese medicine is prepared from the following raw materials in parts by weight: 20-40 parts of trichosanthes kirilowii maxim, 5-20 parts of longstamen onion bulb, 10-25 parts of pinellia ternate, 10-20 parts of radix bupleuri, 5-15 parts of fructus aurantii immaturus, 5-15 parts of honey-fried licorice root, 5-20 parts of radix paeoniae rubra, 5-15 parts of inula flowers, 10-30 parts of raw hawthorn, 10-20 parts of kudzu vine root, 10-20 parts of gingko leaves, 10-20 parts of codonopsis pilosula, 10-20 parts of acorus tatarinowii, 10-20 parts of radix curcumae and 10-20 parts of ligusticum wallichii. The traditional Chinese medicine has the advantages of no side effect and high cure rate.
Description
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of coronary heart disease, belong to the technical field of Chinese medicines for the treatment of coronary heart disease.
Background technology
Coronary heart disease is called for short coronary heart disease, refer to due to lipid metabolism not erect image, lipid in blood is calm on the endarterium of otherwise smooth, pile up at the lipid material of some similar medicated porridge samples of endarterium and form white speckle, current doctor trained in Western medicine adopts blood fat reducing, blood vessel dilating, symptomatic treatment, adopt operative treatment when being in a bad way, cause very large financial burden to patient home.
Summary of the invention
" thoracic obstruction " that the so-called coronary heart disease of western medicine is equivalent to the traditional Chinese medical science " Medical Treasures of the Golden Chamber " and on this this book by the etiology and pathogenesis root of this disease without draw together for " weak pulse at YANG and stringy pulse at YIN " refers to YANG QI deficiency in the heart, instead make the part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels, expectorant muddy water heresy is gone against one's superiors in an opponent's defence, heart numbness is hindered, QI and blood is obstructed, the present invention provides one to have no side effect for above-mentioned etiology and pathogenesis exactly, the Chinese medicine of the treatment coronary heart disease that cure rate is high.
For realizing above-mentioned purpose of the present invention, the present invention adopts following technical scheme, is of the present inventionly made up of following crude drug: Fructus Trichosanthis 20-40 part, Bulbus Allii Macrostemonis 5-20 part, Rhizoma Pinelliae 10-25 part, Radix Bupleuri 10-20 part, Fructus Aurantii Immaturus 5-15 part, Radix Glycyrrhizae Preparata 5-15 part, Radix Paeoniae Rubra 5-20 part, Flos Inulae 5-15 part, Fructus Crataegi 10-30 part, Radix Puerariae 10-20 part, Folium Ginkgo 10-20 part, Radix Codonopsis 10-20 part, Chang foretells 10-20 part, Radix Curcumae 10-20 part, Rhizoma Chuanxiong 10-20 part.
Further, described a kind of Chinese medicine for the treatment of coronary heart disease, is made up of following crude drug: Fructus Trichosanthis 20 parts, Bulbus Allii Macrostemonis 5 parts, the Rhizoma Pinelliae 10 parts, Radix Bupleuri 10 parts, Fructus Aurantii Immaturus 5 parts, Radix Glycyrrhizae Preparata 5 parts, Radix Paeoniae Rubra 5 parts, Flos Inulae 5 parts, Fructus Crataegi 10 parts, Radix Puerariae 10 parts, Folium Ginkgo 10 parts, Radix Codonopsis 10 parts, Chang foretells 10 parts, Radix Curcumae 10 parts, Rhizoma Chuanxiong 10 parts.
Further, described a kind of Chinese medicine for the treatment of coronary heart disease, is made up of following crude drug: Fructus Trichosanthis 30 parts, Bulbus Allii Macrostemonis 12 parts, the Rhizoma Pinelliae 17 parts, Radix Bupleuri 15 parts, Fructus Aurantii Immaturus 10 parts, Radix Glycyrrhizae Preparata 10 parts, Radix Paeoniae Rubra 12 parts, Flos Inulae 10 parts, Fructus Crataegi 20 parts, Radix Puerariae 15 parts, Folium Ginkgo 15 parts, Radix Codonopsis 15 parts, Chang foretells 15 parts, Radix Curcumae 15 parts, Rhizoma Chuanxiong 15 parts.
Further, described a kind of Chinese medicine for the treatment of coronary heart disease is following crude drug composition: Fructus Trichosanthis 40 parts, Bulbus Allii Macrostemonis 20 parts, the Rhizoma Pinelliae 25 parts, Radix Bupleuri 20 parts, Fructus Aurantii Immaturus 15 parts, Radix Glycyrrhizae Preparata 15 parts, Radix Paeoniae Rubra 20 parts, Flos Inulae 15 parts, Fructus Crataegi 30 parts, Radix Puerariae 20 parts, Folium Ginkgo 20 parts, Radix Codonopsis 20 parts, Chang foretells 20 parts, Radix Curcumae 20 parts, Rhizoma Chuanxiong 20 parts.
Beneficial effect of the present invention: Fructus Trichosanthis: removing heat from the lung and dissipating phlegm, promoting the circulation of QI the chest stuffiness relieving, dispersing swelling and dissipating binds, laxation relieving constipation.Bulbus Allii Macrostemonis: activating YANG and eliminating stagnation, circulation of qi promoting intestinal stasis relieving.Preventing or arresting vomiting, falls in the Rhizoma Pinelliae: drying dampness to eliminate phlegm, dissolving lump and resolving mass.Radix Bupleuri; Induce sweat and bring down a fever, dispersing the stagnated live-QI to relieve the stagnation of QI.Fructus Aurantii Immaturus: dispelling the stagnated QI effect is long-pending reduces phlegm except painful abdominal mass.Radix Glycyrrhizae Preparata; QI invigorating invigorating middle warmer, expelling phlegm for arresting cough.Radix Paeoniae Rubra: removing heat from blood reduces phlegm and invigorates blood circulation.Revolve summer flower: expectorant row water, sending down the abnormal ascending QI preventing or arresting vomiting.Fructus Crataegi: blood circulation promoting and blood stasis dispelling, promoting digestion and removing stagnation.Radix Puerariae: coronary artery dilator, improves cardiac function.Folium Ginkgo: an expansion hat tremulous pulse.Blood circulation promoting and blood stasis dispelling.Radix Codonopsis: invigorating the spleen and replenishing QI.Promote the production of body fluid and nourish blood.Chang foretells: causing resuscitation with aromatic drugs, reduces phlegm.Radix Curcumae: blood circulation promoting and blood stasis dispelling circulation of qi promoting.Rhizoma Chuanxiong; Blood circulation promoting and blood stasis dispelling circulation of qi promoting.Whole scheme is: the logical breast sun of temperature, and suitable numbness of reducing phlegm: depressed liver-energy dispersing and QI regulating, activating blood circulation to dissipate blood stasis and dredge the collateral, is applicable to coronary heart disease, angina pectoris, the treatment of myocardial infarction, applies to clinical, can alleviate patient's misery, prevent aggravation, thus cures this disease, and cure rate is high.
Detailed description of the invention
The present invention is made up of following crude drug: Fructus Trichosanthis 20-40 part, Bulbus Allii Macrostemonis 5-20 part, Rhizoma Pinelliae 10-25 part, Radix Bupleuri 10-20 part, Fructus Aurantii Immaturus 5-15 part, Radix Glycyrrhizae Preparata 5-15 part, Radix Paeoniae Rubra 5-20 part, Flos Inulae 5-15 part, Fructus Crataegi 10-30 part, Radix Puerariae 10-20 part, Folium Ginkgo 10-20 part, Radix Codonopsis 10-20 part, Chang foretells 10-20 part, Radix Curcumae 10-20 part, Rhizoma Chuanxiong 10-20 part.
Method of administration: to extract through suitable method to add medicine to, heats with suitable substrate after refining, melting is wet even, instills the yearningly not molten mutually glomerate dropping pill formulation of cooling medium system, each serving 10 balls, every day 3 one after each meals.
Medicine contraindication: do not eat raw and cold irritating food, note warming, emotion is not exciting, keeps free movement of the bowels.
Embodiment 1: Fructus Trichosanthis 20 parts, Bulbus Allii Macrostemonis 5 parts, the Rhizoma Pinelliae 10 parts, Radix Bupleuri 10 parts, Fructus Aurantii Immaturus 5 parts, Radix Glycyrrhizae Preparata 5 parts, Radix Paeoniae Rubra 5 parts, Flos Inulae 5 parts, Fructus Crataegi 10 parts, Radix Puerariae 10 parts, Folium Ginkgo 10 parts, Radix Codonopsis 10 parts, Chang foretells 10 parts, Radix Curcumae 10 parts, Rhizoma Chuanxiong 10 parts.
Embodiment 2: Fructus Trichosanthis 30 parts, Bulbus Allii Macrostemonis 12 parts, the Rhizoma Pinelliae 17 parts, Radix Bupleuri 15 parts, Fructus Aurantii Immaturus 10 parts, Radix Glycyrrhizae Preparata 10 parts, Radix Paeoniae Rubra 12 parts, Flos Inulae 10 parts, Fructus Crataegi 20 parts, Radix Puerariae 15 parts, Folium Ginkgo 15 parts, Radix Codonopsis 15 parts, Chang foretells 15 parts, Radix Curcumae 15 parts, Rhizoma Chuanxiong 15 parts.
Embodiment 3: Fructus Trichosanthis 40 parts, Bulbus Allii Macrostemonis 20 parts, the Rhizoma Pinelliae 25 parts, Radix Bupleuri 20 parts, Fructus Aurantii Immaturus 15 parts, Radix Glycyrrhizae Preparata 15 parts, Radix Paeoniae Rubra 20 parts, Flos Inulae 15 parts, Fructus Crataegi 30 parts, Radix Puerariae 20 parts, Folium Ginkgo 20 parts, Radix Codonopsis 20 parts, Chang foretells 20 parts, Radix Curcumae 20 parts, Rhizoma Chuanxiong 20 parts.
Case 1: Mrs Wang 55 years old symptom: suffer from coronary heart disease 5 years, and quarrels because of house hold affairs with daughter-in-law for 2 months, cause having palpitation, breathe hard, breathe heavily, unable, urgency uncomfortable in chest looks for me to treat, and takes this pill 10, alleviates after 10 minutes, rear every day 3 times, each 7, take a wheat harvesting period, Be very effective.
Case 2: Zhang. female 50 years old suffers from coronary heart disease 3 years, and take medicine, effect is bad always, and quarrel with others because playing Mah-Jong and cause disease relapse, urgency takes this pill 10 ball, alleviation in 15 minutes, rear every day 2 times, and each 10 take more than half a year and do not reaccess.
Case 3: so-and-so man of field 60 years old is conscious nervous, and breathe hard, dyspnea with rapid and short breath, perspires, weak all over having an electro-cardiogram to county hospital inspection finds coronary heart disease, and hospital opens steady anxious granule, metoprolol, and compound Salviae Miltiorrhizae compares DeGrain, after look for me to treat, give clothes time pill 10, after alleviating each 10.Day takes for 3 times, adheres to more than 1 year, and heart keeps good.
Above-described embodiment is only used for further illustrating the coronary heart disease drop pill of invention, but invention is not limited to embodiment, and every any simple modification equivalent variations done above embodiment according to technical spirit of the present invention all falls into the present invention with modifying.
Claims (4)
1. treat a Chinese medicine for coronary heart disease, it is characterized in that, be made up of following crude drug: Fructus Trichosanthis 20-40 part, Bulbus Allii Macrostemonis 5-20 part, Rhizoma Pinelliae 10-25 part, Radix Bupleuri 10-20 part, Fructus Aurantii Immaturus 5-15 part, Radix Glycyrrhizae Preparata 5-15 part, Radix Paeoniae Rubra 5-20 part, Flos Inulae 5-15 part, Fructus Crataegi 10-30 part, Radix Puerariae 10-20 part, Folium Ginkgo 10-20 part, Radix Codonopsis 10-20 part, Chang foretells 10-20 part, Radix Curcumae 10-20 part, Rhizoma Chuanxiong 10-20 part.
2. a kind of Chinese medicine for the treatment of coronary heart disease according to claim 1, is characterized in that, be made up of following crude drug: Fructus Trichosanthis 20 parts, Bulbus Allii Macrostemonis 5 parts, the Rhizoma Pinelliae 10 parts, Radix Bupleuri 10 parts, Fructus Aurantii Immaturus 5 parts, Radix Glycyrrhizae Preparata 5 parts, Radix Paeoniae Rubra 5 parts, Flos Inulae 5 parts, Fructus Crataegi 10 parts, Radix Puerariae 10 parts, Folium Ginkgo 10 parts, Radix Codonopsis 10 parts, Chang foretells 10 parts, Radix Curcumae 10 parts, Rhizoma Chuanxiong 10 parts.
3. a kind of Chinese medicine for the treatment of coronary heart disease according to claim 1, is characterized in that, be made up of following crude drug: Fructus Trichosanthis 30 parts, Bulbus Allii Macrostemonis 12 parts, the Rhizoma Pinelliae 17 parts, Radix Bupleuri 15 parts, Fructus Aurantii Immaturus 10 parts, Radix Glycyrrhizae Preparata 10 parts, Radix Paeoniae Rubra 12 parts, Flos Inulae 10 parts, Fructus Crataegi 20 parts, Radix Puerariae 15 parts, Folium Ginkgo 15 parts, Radix Codonopsis 15 parts, Chang foretells 15 parts, Radix Curcumae 15 parts, Rhizoma Chuanxiong 15 parts.
4. a kind of Chinese medicine for the treatment of coronary heart disease according to claim 1, is characterized in that, is following crude drug composition: Fructus Trichosanthis 40 parts, Bulbus Allii Macrostemonis 20 parts, the Rhizoma Pinelliae 25 parts, Radix Bupleuri 20 parts, Fructus Aurantii Immaturus 15 parts, Radix Glycyrrhizae Preparata 15 parts, Radix Paeoniae Rubra 20 parts, Flos Inulae 15 parts, Fructus Crataegi 30 parts, Radix Puerariae 20 parts, Folium Ginkgo 20 parts, Radix Codonopsis 20 parts, Chang foretells 20 parts, Radix Curcumae 20 parts, Rhizoma Chuanxiong 20 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510687048.9A CN105148206A (en) | 2015-10-22 | 2015-10-22 | Traditional Chinese medicine for treating coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510687048.9A CN105148206A (en) | 2015-10-22 | 2015-10-22 | Traditional Chinese medicine for treating coronary heart disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105148206A true CN105148206A (en) | 2015-12-16 |
Family
ID=54789467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510687048.9A Pending CN105148206A (en) | 2015-10-22 | 2015-10-22 | Traditional Chinese medicine for treating coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105148206A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116942771A (en) * | 2023-08-20 | 2023-10-27 | 谷医堂(湖南)健康科技有限公司 | Traditional Chinese medicine composition for treating coronary heart disease and application thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102698234A (en) * | 2012-06-09 | 2012-10-03 | 李承平 | Tablet for activating yang, removing stasis, promoting circulation of qi, and widening chest |
| CN104138565A (en) * | 2013-05-10 | 2014-11-12 | 哈尔滨济博生物技术开发有限公司 | Medicine for treating angina pectoris turbid phlegm internal stagnation type coronary heart disease |
| CN104225217A (en) * | 2014-10-15 | 2014-12-24 | 辽宁中医药大学 | Chinese herba preparation for treating coronary heart disease and preparation method thereof |
-
2015
- 2015-10-22 CN CN201510687048.9A patent/CN105148206A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102698234A (en) * | 2012-06-09 | 2012-10-03 | 李承平 | Tablet for activating yang, removing stasis, promoting circulation of qi, and widening chest |
| CN104138565A (en) * | 2013-05-10 | 2014-11-12 | 哈尔滨济博生物技术开发有限公司 | Medicine for treating angina pectoris turbid phlegm internal stagnation type coronary heart disease |
| CN104225217A (en) * | 2014-10-15 | 2014-12-24 | 辽宁中医药大学 | Chinese herba preparation for treating coronary heart disease and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 东方: "自拟理气通脉汤治疗冠心病心绞痛70例观察", 《中国民康医学》 * |
| 高彩霞等: "路志正调理脾胃法治疗胸痹58例临床观察报告", 《河南中医》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116942771A (en) * | 2023-08-20 | 2023-10-27 | 谷医堂(湖南)健康科技有限公司 | Traditional Chinese medicine composition for treating coronary heart disease and application thereof |
| CN116942771B (en) * | 2023-08-20 | 2023-12-22 | 谷医堂(湖南)健康科技有限公司 | Traditional Chinese medicine composition for treating coronary heart disease and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103816498A (en) | Traditional Chinese medicine mixture for treating sleep disorders | |
| CN103784802A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN104043057A (en) | Traditional Chinese medicinal composition for treating lymph cancer | |
| CN102847061B (en) | Traditional Chinese medicine preparation for treating pediatric viral myocarditis and preparation method thereof | |
| CN104147549A (en) | Medicine for treating hypertension | |
| CN103169931A (en) | Traditional Chinese medicine composition for treating spleen-deficiency abdominal distention | |
| CN104888152A (en) | Traditional Chinese medicine preparation for treating postpartum depression and preparation method therefor | |
| CN105796789A (en) | Traditional Chinese medicine preparation for treating coronary heart disease | |
| CN105148206A (en) | Traditional Chinese medicine for treating coronary heart disease | |
| CN105055966A (en) | Traditional Chinese medicine composition for treating puerperal disease | |
| CN104800772A (en) | Traditional Chinese medicine composition for treating vital-energy-depression type coronary heart disease and application of traditional Chinese medicine composition | |
| CN104873911A (en) | Traditional Chinese medicine for oral administration for adjunctively treating sepsis | |
| CN104689252A (en) | Traditional Chinese preparation for treating Wegener granulomatosis and preparation method thereof | |
| CN104258351A (en) | Traditional Chinese medicine preparation for treating alcoholic cardiomyopathy and preparation method of preparation | |
| CN104547369A (en) | Oral medicine for treating blepharospasm and preparation method thereof | |
| CN103690757B (en) | Traditional Chinese medicine composition for treating lung-spleen deficiency child bronchitis | |
| CN103638275B (en) | Chinese medicinal formulae of a kind of coronary flow that increases sharply and preparation method thereof | |
| CN105943639A (en) | Traditional Chinese medicine composition assisting in treating chronic subdural hematoma | |
| CN104524535A (en) | Traditional Chinese medicine composition for treating chronic pulmonary heart disease and preparation method of traditional Chinese medicine composition | |
| CN105456951A (en) | Traditional Chinese medicine preparation for treating breast fibroadenoma and preparing method of traditional Chinese medicine preparation | |
| CN104645247A (en) | Traditional Chinese medicine preparation for treating hepatolenticular degeneration and preparation method of traditional Chinese medicine preparation | |
| CN104306943A (en) | Traditional Chinese medicine combination for curing hyperlipidemia | |
| CN105687702A (en) | Hyperhidrosis treatment medicine | |
| CN104399038A (en) | Drug for treating gastritis and preparation method thereof | |
| CN103356970A (en) | Traditional Chinese medicine composition for treating mammary gland hyperplasia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20151216 |
|
| WD01 | Invention patent application deemed withdrawn after publication |